NCT04140188

SLNB After Nipple Sparing Mastectomy

Sentinel Lymph Node Biopsy After Nipple Sparing Mastectomy: Prospective Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Acibadem University · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Sentinel Lymph Node Biopsy (SLNB) after nipple sparing mastectomy (NSM) is controversial. This study aims to investigate feasibility of SLNB with radioisotope method.

Detailed description

Volunteer patients who has underwent to NSM at least more than 6 months prior will be included to the study. Radioisotope will be injected via intradermal route to the breast underwent to NSM patients and lymphoscintigraphy images will be obtained to detect activity in axilla. If hot nodule is detected then it will be concluded that SLNB can be performed after NSM.

Conditions

• Sentinel Lymph Node Biopsy
• Mastectomy, Subcutaneous

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Senti-Scint (99mTc- pertechnetate combined with human albumin)	Senti-Scint will be injected via intradermal route to the breast with history of previous NSM.

Timeline

• Start date: 2019-11-01
• Primary completion: 2020-04-01
• Completion: 2020-06-01
• First posted: 2019-10-25
• Last updated: 2019-10-29

Locations

1 site across 1 country: Turkey (Türkiye)